Examining Need For Increased Investment Into Africa’s Pharmaceutical Production Industry

Writing in the Global Health Corps “Fellows” blog, fellow Brian Ngwatu from Uganda argues for increased investment in the local pharmaceutical production industry in Africa, which boasts “11 percent of the world’s population and 25 percent of the global disease burden” but “only one percent share of the world’s pharmaceutical markets.” He notes “two thirds of the global value of pharmaceutical products is produced in five countries (U.S., Japan, France, Germany and the U.K.) where the global disease burden is negligible,” and writes, “I can’t help but think of the significant amounts of donor money flowing into the purchase of [antiretroviral drugs (ARVs)] and other essential medicines in sub-Saharan Africa that could be diverted into local pharmacy production instead of flowing to multinational corporations and Indian generic manufacturers” (8/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.